Skip to main content
Erschienen in: Intensive Care Medicine 6/2014

01.06.2014 | Understanding the Disease

Understanding paracetamol-induced liver failure

verfasst von: Fin Stolze Larsen, Julia Wendon

Erschienen in: Intensive Care Medicine | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Excerpt

Paracetamol (N-acetyl-p-aminophenol) is among the most widely used over-the-counter antipyretic and analgesic drugs. Paracetamol is generally considered to be safe at recommended therapeutic doses but concerns accumulate worldwide, as it has been recognized as a frequent cause of acute liver failure (ALF). …
Literatur
1.
Zurück zum Zitat Prescott LF (1979) Paracetamol poisoning. Prevention of liver damage. Med Chir Dig 8:391–393PubMed Prescott LF (1979) Paracetamol poisoning. Prevention of liver damage. Med Chir Dig 8:391–393PubMed
2.
Zurück zum Zitat Khalid SK, Lane J, Navarro V, Garcia-Tsao G (2009) Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis. Clin Gastroenterol Hepatol 7(9):994–999PubMedCentralPubMedCrossRef Khalid SK, Lane J, Navarro V, Garcia-Tsao G (2009) Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis. Clin Gastroenterol Hepatol 7(9):994–999PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Prescott LF (1996) Hepatotoxicity. In: Prescott LF (ed) Paracetamol (acetaminophen): a critical bibliographic review. Taylor & Francis, London, pp 285–351 Prescott LF (1996) Hepatotoxicity. In: Prescott LF (ed) Paracetamol (acetaminophen): a critical bibliographic review. Taylor & Francis, London, pp 285–351
4.
Zurück zum Zitat Clemmesen JO, Kondrup J, Ott P (2000) Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology 118(6):1131–1139PubMedCrossRef Clemmesen JO, Kondrup J, Ott P (2000) Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology 118(6):1131–1139PubMedCrossRef
5.
Zurück zum Zitat Cordoba J, Ventura-Cots M, Simón-Talero M, Amorós A, Pavesi M, Vilstrup H, Angeli P, Domenicali M, Ginés P, Bernardi M, Arroyo V, CANONIC Study Investigators of the EASL-CLIF Consortium (2014) Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol 60(2):275–281PubMedCrossRef Cordoba J, Ventura-Cots M, Simón-Talero M, Amorós A, Pavesi M, Vilstrup H, Angeli P, Domenicali M, Ginés P, Bernardi M, Arroyo V, CANONIC Study Investigators of the EASL-CLIF Consortium (2014) Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol 60(2):275–281PubMedCrossRef
7.
Zurück zum Zitat Schmidt LE, Larsen FS (2006) Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit Care Med 34(2):337–343PubMedCrossRef Schmidt LE, Larsen FS (2006) Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit Care Med 34(2):337–343PubMedCrossRef
8.
Zurück zum Zitat Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P (1999) Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29(3):648–653PubMedCrossRef Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P (1999) Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29(3):648–653PubMedCrossRef
9.
Zurück zum Zitat Shawcross DL, Wendon JA (2012) The neurological manifestations of acute liver failure. Neurochem Int 60(7):662–671PubMedCrossRef Shawcross DL, Wendon JA (2012) The neurological manifestations of acute liver failure. Neurochem Int 60(7):662–671PubMedCrossRef
10.
Zurück zum Zitat Antoniades CG, Khamri W, Abeles RD, Taams LS, Triantafyllou E, Possamai LA, Bernsmeier C, Mitry RR, O’Brien A, Gilroy D, Goldin R, Heneghan M, Heaton N, Jassem W, Bernal W, Vergani D, Ma Y, Quaglia A, Wendon J, Thursz M (2013) Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen induced acute liver failure. Hepatology 59(4):1564–1576. doi:10.1002/hep.26933 CrossRef Antoniades CG, Khamri W, Abeles RD, Taams LS, Triantafyllou E, Possamai LA, Bernsmeier C, Mitry RR, O’Brien A, Gilroy D, Goldin R, Heneghan M, Heaton N, Jassem W, Bernal W, Vergani D, Ma Y, Quaglia A, Wendon J, Thursz M (2013) Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen induced acute liver failure. Hepatology 59(4):1564–1576. doi:10.​1002/​hep.​26933 CrossRef
11.
Zurück zum Zitat Stravitz RT, Lisman T, Luketic VA et al (2012) Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol 56:129–136PubMedCrossRef Stravitz RT, Lisman T, Luketic VA et al (2012) Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol 56:129–136PubMedCrossRef
12.
Zurück zum Zitat Simpson KJ, Bates CM, Henderson NC et al (2009) The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies. Liver Transpl 15:600–609PubMedCrossRef Simpson KJ, Bates CM, Henderson NC et al (2009) The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies. Liver Transpl 15:600–609PubMedCrossRef
13.
Zurück zum Zitat Harrison PM, Keays R, Bray GP, Alexander GJ, Williams R (1990) Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of N-acetylcysteine. Lancet 335(8705):1572–1573PubMedCrossRef Harrison PM, Keays R, Bray GP, Alexander GJ, Williams R (1990) Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of N-acetylcysteine. Lancet 335(8705):1572–1573PubMedCrossRef
14.
Zurück zum Zitat Schmidt LE, Wang LP, Hansen BA, Larsen FS (2003) Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 9(3):290–297PubMedCrossRef Schmidt LE, Wang LP, Hansen BA, Larsen FS (2003) Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 9(3):290–297PubMedCrossRef
15.
Zurück zum Zitat Saliba F, Camus C, Durand F, Mathurin P, Letierce A, Delafosse B, Barange K, Perrigault PF, Belnard M, Ichaï P, Samuel D (2013) Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med 159(8):522–531PubMedCrossRef Saliba F, Camus C, Durand F, Mathurin P, Letierce A, Delafosse B, Barange K, Perrigault PF, Belnard M, Ichaï P, Samuel D (2013) Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med 159(8):522–531PubMedCrossRef
Metadaten
Titel
Understanding paracetamol-induced liver failure
verfasst von
Fin Stolze Larsen
Julia Wendon
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 6/2014
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-014-3293-9

Weitere Artikel der Ausgabe 6/2014

Intensive Care Medicine 6/2014 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.